For people living with both type 2 diabetes and obesity, a prescriber might consider either, alongside other medications, based on the wider picture of someones health
These type of medications have been used for over a decade in treating type 2 diabetes
While most patients report improved mood during treatment, some experience low mood or anxiety
Among commercially insured non-diabetic individuals with obesity, people who identified as female, received point-of-service or preferred provider organization insurance coverage, and who took medications such as antidepressants or thyroid or hormone medications, were more likely to begin taking semaglutide compared to people who identified as males, or those who were covered by health management organization or exclusive provider organization plans
These factors contribute to its remarkable effectiveness in tirzepatide weight loss, often surpassing other available treatments